Showing results (141-150 of 516) with videos related to

Sort By:
Pageof 52
Frontiers in Immunology|January 26, 2024
IgG in the control of FcεRI activation: a battle on multiple frontsFederico Storni, Monique Vogel, Martin F Bachmann, et al.
Allergy|March 12, 2026
A Case for Anti-IgE VaccinationPaul Engeroff, Zahra Gharailoo, Monique Vogel, et al.
European Journal of Biochemistry|November 3, 1986
High-affinity binding sites for human Glu-plasminogen unveiled by limited plasmic degradation of human fibrinC Tran-Thang, E K Kruithof, J Atkinson, et al.
Cytometry|February 13, 2001
Green fluorescent protein as a novel tool to measure apoptosis and necrosisA Strebel, T Harr, F Bachmann, et al.
Medical Microbiology and Immunology|May 1, 1994
Immunogenicity of a viral model vaccine after different inactivation proceduresM F Bachmann, C Bast, H Hengartner, et al.
Expert Review of Clinical Immunology|June 6, 2014
Immunotherapy of type-1 allergies with virus-like particles and CpG-motifsLudger Klimek, Martin F Bachmann, Gabriela Senti, et al.
European Journal of Immunology|March 4, 1998
Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infectionA Oxenius, M F Bachmann, R M Zinkernagel, et al.
Schweizerische Medizinische Wochenschrift|March 7, 1992
[Hemophilia C, a deficiency of a contact phase protein which may involve a risk of hemorrhage]C Francillon, H Knecht, L Winkel, et al.
Blood|October 1, 1984
Demonstration of a fast-acting inhibitor of plasminogen activators in human plasmaE K Kruithof, C Tran-Thang, A Ransijn, et al.
Microbes and Infection|February 20, 2007
Heterogeneous antibody repertoire of marginal zone B cells specific for virus-like particlesDominique Gatto, Monika Bauer, Stephen W Martin, et al.
Pageof 52